EBS vs EBON: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

EBS has stronger fundamentals based on our AI analysis.

EBS
Emergent BioSolutions Inc.
BUY
72%
Confidence
VS
EBON
Ebang International Holdings Inc.
SELL
95%
Confidence

EBS vs EBON Fundamental Comparison

Metric EBS EBON
Revenue $742.9M N/A
Net Income $52.6M N/A
Net Margin 7.1% N/A
ROE 10.1% N/A
ROA 4.0% N/A
Current Ratio 5.01x N/A
Debt/Equity 1.13x N/A
EPS $0.93 N/A

Green = Better metric | Red = Weaker metric

View Full EBS Analysis →
View Full EBON Analysis →

You Might Also Compare

EBS vs AAPL EBON vs MSFT EBS vs GOOGL EBON vs AMZN

EBS vs EBON: Frequently Asked Questions

Is EBS or EBON a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), EBS has stronger fundamentals. EBS is rated BUY (72% confidence) while EBON is rated SELL (95% confidence). This is not investment advice.

How does EBS compare to EBON fundamentally?

Emergent BioSolutions Inc. has ROE of 10.1% vs Ebang International Holdings Inc.'s N/A. Net margins are 7.1% vs N/A respectively.

Which stock pays higher dividends, EBS or EBON?

EBS has a dividend yield of N/A or no dividend while EBON has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in EBS or EBON for long term?

For long-term investing, consider that EBS has BUY rating with 72% confidence, while EBON has SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about EBS vs EBON?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EBS vs EBON, the AI consensus favors EBS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.